PharmaVoice

APRIL 15, 2024

The biotech is developing a ‘gene-agnostic’ approach to expand the patient pool for gene therapies.

363

363

STAT

APRIL 15, 2024

Nearly a decade ago, venture capitalist Bob Nelsen called industry veteran Vicki Sato to pitch her on launching a large company dedicated to tackling the world’s worst pathogens. “This is a crazy idea,” Sato said. Nelsen, managing director of ARCH Venture, had made a name and fortune off crazy ideas, but generally it was the science that sounded crazy: engineering cells to cure cancer, finding drugs to slow aging.

360

360

Pharma Times

APRIL 15, 2024

Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis

150

150

STAT

APRIL 15, 2024

The number of new prescriptions written for biosimilar versions of the Humira rheumatoid arthritis treatment, one of the best-selling medicines in the U.S., surged to 36% from just 5% during the first week of April, thanks to the expanding reach that CVS Health has over the prescription drug market. The big jump was attributed to one particular biosimilar called Hyrimoz, which is manufactured by Sandoz, a unit of Novartis that is a leading supplier of generic and biosimilar medicines.

Biosimilars 329

Biosimilars Drug Pricing 329

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharma Times

APRIL 15, 2024

Approximately 14% of the competition-submitted proposals were selected to receive funding

141

141

PharmaVoice

APRIL 15, 2024

As GLP-1s expand into new disease categories, their impact could be enough to overtake leading cardiovascular drugs.

130

130

STAT

APRIL 15, 2024

CHICAGO — The split between Dana-Farber Cancer Institute and Mass General Brigham has been messy. Some people who don’t see breakups coming wonder what went wrong, and maybe channel the sorrow into a love ballad. But Mass General Brigham is taking a different tack — it’s simply getting over it. The $20 billion nonprofit hospital system is now plotting out how its cancer programs will look in a post-Dana-Farber world.

Hospitals 309

Hospitals 309

BioPharma Dive

APRIL 15, 2024

Treatment appeared to result in functional and cognitive gains in people with the neurological disorder. Three participants experienced lower extremity weakness, however.

122

122

STAT

APRIL 15, 2024

Ultragenyx has found early success with its experimental treatment for the rare disease Angelman syndrome, supporting the company’s decision to acquire its development partner two years ago. Ultragenyx is one of the few companies developing a treatment for Angelman syndrome , a genetic condition that causes delayed development, problems with speech and balance, mental disability, and sometimes seizures.

Communication 295

Communication 295

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

APRIL 15, 2024

Psychedelic treatments for conditions like PTSD using substances like MDMA are on the brink of approval, but there are still unanswered questions surrounding their effectiveness and potential risks. Learn more here.

122

122

STAT

APRIL 15, 2024

Telehealth company Cerebral will limit the consumer health data it uses for advertising purposes under a new order announced by the Federal Trade Commission Monday. Cerebral, a startup best known for dispensing counseling services and prescriptions for conditions like anxiety and depression, has also agreed to pay $7 million to resolve charges that it disclosed customers’ personal health information to third parties for ads, and that it did not honor its promise to make cancellation easy

289

289

EMCrit Project

APRIL 15, 2024

A razor is a rule of thumb that is helpful, although it isn't always correct. In medicine we're familiar with Occam's razor (the rule of parsimony). The cutoff razor states: if a continuous variable is dichotomized using a cutoff, then values near the cutoff provide little information. A simple illustration of the cutoff razor is […] EMCrit Project by Josh Farkas.

120

120

STAT

APRIL 15, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and refreshing, because that oh-so familiar routine of phone calls, online meetings, and rushing about has predictably returned. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup or three of stimulation.

268

268

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

APRIL 15, 2024

Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology” start-ups.

119

119

STAT

APRIL 15, 2024

You’re reading the web version of Health Care Inc.,  STAT’s weekly newsletter  following the flow of money in medicine.  Sign up  to get it in your inbox every Monday.  Anne Klibanski on the Dana-Farber split Mass General Brigham didn’t foresee the breakup with Dana-Farber Cancer Institute. But there won’t be any texts begging Dana-Farber to come back.

Hospitals 260

Hospitals 260

The Pharmacist

APRIL 15, 2024

A medicine for type 2 diabetes may slow the progression of the symptoms of Parkinson’s disease, research has suggested. Investigators evaluating the glucagon-like peptide 1 receptor agonist (GLP-1 RA) lixisenatide reported less progression of motor disability over a 12-month period in patients taking the drug compared with placebo. But writing in the New England Journal of Medicine, they […] The post Diabetes drug shows potential in treating Parkinson’s disease appeared first on The Pharma

Diabetes 114

Diabetes 114

STAT

APRIL 15, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hi there, Meghana here — a little wistful about the departure of the illustrious Damian Garde but extremely excited about a fantastic newsletter co-author we’ll introduce soon.

Drug Pricing 218

Drug Pricing Drug Development 218

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

APRIL 15, 2024

Shah Capital has fired a broadside at the management team of Novavax, seeking a change in leadership at the vaccine company and the appointment of two handpicked directors to the board. In an open letter, the hedge fund accuses Novavax’s leadership of squandering its “many significant competitive advantages and sizeable market opportunity” due to “self-inflicted problems” under the current team led by chief executive John Jacobs.

Vaccines 111

Vaccines 111

The Pharmacist

APRIL 15, 2024

The NHS national booking system for spring Covid-19 vaccination bookings via pharmacies in England is now open. Those eligible to book appointments are able to do so for next week. They include adults aged 75 or over as of 30 June 2024, residents in care homes for older adults, and individuals who are immunosuppressed. The […] The post NHS opens national booking system for spring Covid-19 vaccinations appeared first on The Pharmacist.

Vaccines 111

Vaccines 111

pharmaphorum

APRIL 15, 2024

Roche’s CD20xCD3 bispecific antibody Columvi has improved survival when used as a second-line therapy for diffuse large B-cell lymphoma (DLBCL) in a phase 3 trial, setting up regulatory filings for earlier use of the drug in the treatment pathway.

110

110

BioPharma Dive

APRIL 15, 2024

The results could give Roche’s Columvi an edge over a rival medicine from AbbVie and Genmab, while Regeneron awaits an approval of its own therapy.

110

110

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

APRIL 15, 2024

The advancement of medicine is dependent on secure pharmaceutical supply chains. Discover why ensuring the security of these chains is crucial for the development and distribution of life-saving medications.

105

105

Pharmaceutical Commerce

APRIL 15, 2024

Results of the trial suggest that early intervention for intracerebral hemorrhage using parafascicular surgery were safe.

105

105

pharmaphorum

APRIL 15, 2024

Life sciences service provider (and pharmaphorum parent company) Eversana has completed the integration of Healthware Group, the Italy-based global agency and consultancy it acquired in October. The group will now be known as Eversana Intouch Healthware and will operate as Eversana’s sixth full-service affiliate.

105

105

Pharmaceutical Commerce

APRIL 15, 2024

The latest news for pharma industry insiders.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.